Naloxone is a well-established essential medicine for the treatment of life-threatening
heroin/opioid overdose in emergency medicine. Over two decades, the concept of 'take …

Background Take home naloxone (THN) programs have been rapidly upscaled in response
to increasing opioid-related mortality. One often cited concern is that naloxone provision …

Background Naloxone-based interventions as part of health systems can reverse an opioid
overdose. Previous systematic reviews have identified the effectiveness of naloxone; …

Background While naloxone, the overdose reversal medication, has been available for
decades, factors associated with its availability through pharmacies remain unclear. Studies …

Objectives Pharmacists are well positioned to identify patients at risk of overdose, dispense
naloxone, and counsel patients on appropriate use. In response to growing numbers of …

Background Opioid related overdoses and overdose deaths continue to constitute an urgent
public health crisis. The implementation of naloxone programs, such as 'take-home …

Aim Given the potential to expand naloxone supply through community pharmacy, the aim of
this study was to estimate Australian pharmacists':(1) level of support for overdose …

Objective: People living with severe and persistent mental illness experience poorer
physical health, often due to medication and preventable lifestyle factors, and exacerbated …

A variety of new sources describing community pharmacy-based take-home naloxone (THN)
programs have emerged recently in the literature. There is a need to define the types of take …

Introduction: Pharmacist roles promoting safe opioid use are recognized in literature and
practice. Pharmacists can offer services such as counseling on opioid risks, naloxone …